Pharmacological effects of N-[2-[[2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetyl]oxy]ethyl]hyaluronamide (diclofenac Etalhyaluronate, SI-613), a novel sodium hyaluronate derivative chemically linked with diclofenac

Peer Review reports

Original Submission
2 Nov 2017	Submitted	Original manuscript
22 Nov 2017	Reviewed	Reviewer Report - Ellen Wasan
20 Mar 2018	Author responded	Author comments - Keiji Yoshioka
Resubmission - Version 2
20 Mar 2018	Submitted	Manuscript version 2
26 Apr 2018	Author responded	Author comments - Keiji Yoshioka
Resubmission - Version 3
26 Apr 2018	Submitted	Manuscript version 3
Publishing
7 May 2018	Editorially accepted
22 May 2018	Article published	10.1186/s12891-018-2077-8

Back to article page